A Case Report of Diffuse Large B-Cell Lymphoma Associated with Epstein-Barr Virus in a Patient with Human Immunodeficiency Virus Infection
Keywords:
Diffuse large B-cell lymphoma, epstein-barr virus infection, epidermotropism, human immunodeficiency virus infectionAbstract
Diffuse large B-cell lymphomas is the most frequent subtype of non-Hodgkin’s lymphomas in both normal populations and human Immunodeficiency virus-infected individuals. Cutaneous involvement can be either primary or secondary. The common cutaneous features are erythematous to violaceous plaques, nodules, or ulcerative lesions. The histopathology typically demonstrates nodular or diffuse infiltration of large atypical lymphocytes with relatively sparing of the epidermis.
We reported a case of HIV infected woman presented with 2-month history of red-purplish rashes distributed all over the body including her face and oral cavity. She also had fever, night sweat, malaise, dysphagia, and significant weight loss. The skin biopsy showed diffuse dermal infiltration of medium to large atypical lymphocytes with epidermotropism. However, the immunohistochemistry demonstrated CD20-positive B lymphocytes in the vast majority of the infiltrating cells. The initial diagnosis was epidermotropic cutaneous B-cell lymphoma mimicking mycosis fungoides. Immunoblastic/activated B-cell subtype of diffuse large B-cell lymphoma was determined by further immunohistochemical study. In addition, Epstein-Barr virus was found obviously positive. According to the overall findings, we reported a case of diffuse large B-cell lymphoma associated with Epstein-Barr virus in a patient with human immunodeficiency virus infection.
References
Shamsudin N, Chang CC. Diffuse large B-cell lymphoma presenting with extensive cutaneous infiltration. Singapore Med J 2012;53:e198-200.
Liu Y, Barta SK. Diffuse large B-cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment. Am J Hematol 2019;94:604-16.
Suárez AL, Pulitzer M, Horwitz S, Moskowitz A, Querfeld C, Myskowski PL. Primary cutaneous B-cell lymphomas: part I. Clinical features, diagnosis, and classification. J Am Acad Dermatol 2013;69:329.e1-13;quiz41-2.
Willemze R, Cerroni L, Kempf W, et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood 2019;133:1703-14.
Slater D. Histopathological aspects of cutaneous lymphoma. J R Soc Med 2001;94:337-40.
Plaza JA, Kacerovska D, Stockman DL, et al. The histomorphologic spectrum of primary cutaneous diffuse large B-cell lymphoma: a study of 79 cases. Am J Dermatopathol 2011;33:649-55;quiz56-8.
Dunleavy K, Wilson WH. How I treat HIV-associated lymphoma. Blood 2012;119:3245-55.
Said J CE, Rosenwald A, Harris NL. Lymphoma associated with HIV infection. In: Swerdlow SH, editor. WHO Classification of Tumours of Haematopoietic and lymphoid tissues. Lyon IARC; 2017.p.449-52.
Aboulafia DM. Non-Hodgkin lymphoma in people with HIV. The lancet HIV 2019;6:e209-e10.
Corti M, Carolis LD, Solari R, et al. Non Hodgkin's lymphoma with cutaneous involvement in AIDS patients: report of five cases and review of the literature. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2010;14:81-5.
Yarchoan R, Uldrick TS. HIV-Associated Cancers and Related Diseases. N Engl J Med 2018;378:1029-41.
Dolcetti R, Gloghini A, Caruso A, Carbone A. A lymphomagenic role for HIV beyond immune suppression? Blood 2016;127:1403-9.
Nakamura S, Jaffe ES, Swerdlow SH. EBV positive diffuse large B-cell lymphoma, not otherwise specified. In: Swerdlow SH, editor. WHO Classification of Tumours of Haematopoietic and lymphoid tissues. Lyon: IARC;2017.p.304-6.
Downloads
Published
How to Cite
Issue
Section
License
เนื้อหาและข้อมูลในบทความที่ลงตีพิมพ์ในวารสารโรคผิวหนัง ถือเป็นข้อคิดเห็นและความรับผิดชอบของผู้เขียนบทความโดยตรงซึ่งกองบรรณาธิการวารสาร ไม่จำเป็นต้องเห็นด้วย หรือร่วมรับผิดชอบใดๆ
บทความ ข้อมูล เนื้อหา รูปภาพ ฯลฯ ที่ได้รับการตีพิมพ์ในวารสารโรคผิวหนัง ถือเป็นลิขสิทธิ์ของวารสารฯ หากบุคคลหรือหน่วยงานใดต้องการนำทั้งหมดหรือส่วนหนึ่งส่วนใดไปเผยแพร่ต่อหรือเพื่อกระทำการใดๆ จะต้องได้รับอนุญาตเป็นลายลักอักษรจากบรรณาธิการวารสารโรคผิวหนังก่อนเท่านั้น